MUC4 and cancer: In a study that was performed to understand the causative mechanism(s) of trastuzumab resistance in breast and some other cancers, it was discovered that MUC4 masks trastuzumab binding epitope of ErbB2, resulting in reduced binding of trastuzumab35.